Company news

MetaVia Inc. news in 2022

MetaVia Inc.'s news releases, calls and decks from 2022, newest first.

View company

NeuroBo announces closing of $32.3 million underwritten public offering including full exercise of overallotment option and concurrent private placement

November 7, 2022

NeuroBo announces pricing of $30 million underwritten public offering and concurrent private placement

November 3, 2022

NeuroBo Pharmaceuticals, Inc. Compliant with All Applicable Nasdaq Listing Criteria

September 28, 2022

NeuroBo Pharmaceuticals Announces Reverse Stock Split

September 11, 2022

NeuroBo Pharmaceuticals, Inc. Expands Management Team with the Appointment of Matthew Bardin, PharmD, BCPS as Senior Vice President Operations

May 5, 2022

NeuroBo Pharmaceuticals Reports Full Year 2021 Financial Results

March 31, 2022

NeuroBo Pharmaceuticals, Inc. Expands Scientific Advisory Board with Appointment of Danamarie Belpulsi, M.D.

March 14, 2022

NeuroBo Pharmaceuticals, Inc. Appoints D. Gordon Strickland to its Board of Directors

January 27, 2022

Decks in 2022